Hepatitis B and immigrants: A SIMIT multicenter cross-sectional study

Infection

Volumn 41, Issue 1, 2013, Pages 53-59

  Fasano, M ^a   Saracino, A ^b   Carosi, G ^c   Mazzotta, F ^d   Marino, N ^d   Sagnelli, E ^e   Gaeta, G B ^f   Angarano, G ^a   Verucchi, G ^g   Bellissima, P ^h   Angeletti, C ⁱ   Santantonio, T ^b  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^e University of Caserta   (Italy)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g UNIVERSITY OF BOLOGNA   (Italy)

^h Clinic of Infectious Diseases   (Italy)

ⁱ NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

HBV genotype; Hepatitis B; Immigrants

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN;

ADULT; AFRICA; AGE; AGED; ANTIVIRAL THERAPY; ARTICLE; CROSS-SECTIONAL STUDY; EASTERN EUROPE; FEMALE; GENOTYPE; HEPATITIS B; HUMAN; IMMIGRANT; ITALY; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST; NORTH AFRICA; PREVALENCE; SEX DIFFERENCE; SOUTH AMERICA; VIRUS CARRIER; WESTERN EUROPE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARRIER STATE; COMORBIDITY; CROSS-SECTIONAL STUDIES; EMIGRANTS AND IMMIGRANTS; FEMALE; HEPATITIS B, CHRONIC; HUMANS; ITALY; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 84873706782     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-012-0384-9     Document Type: Article

References (19)

1. Stroffolini T, Mele A, Tosti ME, et al. The impact of hepatitis B mass immunization campaign on the incidence and risk factors of acute hepatitis B in Italy. J Hepatol. 2000;33:980-5.
2. Stroffolini T. The changing pattern of hepatitis B virus infection over the past three decades in Italy. Dig liver Dis. 2005;37:622-627.
3. Caritas Italiana/Migrantes. Dossier Statistico Immigrazione 2011. XXI Rapporto. Edizioni Idos Roma. http://www.dossierimmigrazione.it/libro.php?cid= 47-52&pid=145.
4. Stroffolini T, Bianco E, Szklo A, et al. Factors affecting the compliance of the antenatal hepatitis B screening programme in Italy. Vaccine. 2003;21:1246-9.
5. Scotto G, Saracino A, Pempinello R, et al.; Gruppo Italiano per lo Studio delle Malattie Infettive negli Immigrati. Epidemiologic multicenter study of the prevalence of hepatitis in hospitalised immigrants in Italy in the year 2002. Ann Ig. 2005;17:11-8.
6. Da Villa G, Romanò L, Sepe A, et al. Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals. Vaccine. 2007;25:3133-6.
7. Spada E, Tosti ME, Zuccaro O, Stroffolini T, Mele A; Collaborating Study Group. Evaluation of the compliance with the protocol for preventing perinatal hepatitis B infection in Italy. J Infect. 2011;62:165-71.
8. Sánchez-Tapias JM, Costa J, Mas A, Bruguera M, Rodés J. Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients. Gastroenterology. 2002;123:1848-56.
9. Yuen MF, Sablon E, Yuan HJ, et al. Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma. Hepatology. 2003;37:562-7.
10. Sumi H, Yokosuka O, Seki N, et al. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology. 2003;37:19-26.
11. McMahon BJ. The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatol Int. 2009;3:334-42.
12. Cao GW. Clinical relevance and public health significance of hepatitis B virus genomic variations. World J Gastroenterol. 2009;15:5761-9.
13. Kurbanov F, Tanaka Y, Mizokami M. Geographical and genetic diversity of the human hepatitis B virus. Hepatol Res. 2010;40:14-30.
14. Lin CL, Kao JH. The clinical implications of hepatitis B virus genotype: recent advances. J Gastroenterol Hepatol. 2011;26:123-30.
15. Almasio PL, Babudieri S, Barbarini G, et al. Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates). Dig Liver Dis. 2011;43:589-95.
16. Veldhuijzen IK, Toy M, Hahné SJ, et al. Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective. Gastroenterology. 2010;138:522-30.
17. Stroffolini T, Almasio PL, Sagnelli E, et al. Evolving clinical landscape of chronic hepatitis B: a multicenter Italian study. J Med Virol. 2009;81:1999-2006.
18. Gaeta GB, Stroffolini T, Chiaramonte M, et al. Chronic hepatitis D: a vanishing disease? An Italian multicenter study. Hepatology. 2000;32:824-7.
19. Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48:335-52.